Mitrakas L, Zisopoulos A, Dimitropoulos K, Siafakas S, et al. Introducing "HEDGE": sequential intravesical gemcitabine-based thermochemotherapy (HIVEC) plus docetaxel as a potential novel bladder-sparing strategy for BCG-unresponsive non-muscle-invasive bladder cancer. Arch Ital Urol Androl 2026 Sep 9:15738. doi: 10.4081/aiua.2026.15738.
PMID: 42714388